Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof
Details for Australian Patent Application No. 2003265269 (hide)
International Classifications
Event Publications
18 December 2003 Complete Application Filed
Priority application(s): 60/319,402 17.07.02 US; 60/426,601 15.11.02 US
18 March 2004 Application Open to Public Inspection
Published as AU-B-2003265269
26 November 2009 Application Accepted
Published as AU-B-2003265269
25 March 2010 Standard Patent Sealed
27 May 2010 Amendment Made
The nature of the amendment is: Amend the invention title to read Flea and tick octopamine receptor nucleic acid molecules, proteins and uses thereof 2003270778 Alpharma, Inc. The nature of the amendment is: Amend the invention title to read Sequestering subunit and related compositions and methods
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003265268-METHODS AND COMPOSITIONS FOR SCREENING CELL BINDING MOLECULES
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser